Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-075198

10% owner bought 454,545 shares at $11.00 ($4,999,995)

  • 10% owner acquired 3,433,646 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

VIVO VENTURES VII, LLC · 10% owner

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2015-10-13 Conversion : show line 1 in the form +3,360,408 3,657,147 I
2015-10-13 Purchase : show line 2 in the form +444,850 $11.00 $4,893,350 4,101,997 I
2015-10-13 Conversion : show line 3 in the form +73,238 79,705 I
2015-10-13 Purchase : show line 4 in the form +9,695 $11.00 $106,645 89,400 I
Open-market purchases · 454,545 sh · avg $11.00 · $4,999,995

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2015-10-13 Conversion : show line 5 in the form Series A Preferred Stock −8,467,943 0 I
2015-10-13 Conversion : show line 6 in the form Series A Preferred Stock −184,557 0 I
2015-10-13 Conversion : show line 7 in the form Series B Preferred Stock −1,779,400 0 I
2015-10-13 Conversion : show line 8 in the form Series B Preferred Stock −38,782 0 I
2015-10-13 Conversion : show line 9 in the form Series C Preferred Stock −1,346,068 0 I
2015-10-13 Conversion : show line 10 in the form Series C Preferred Stock −29,337 0 I
Loading xslF345X03/doc4.xml…